These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 32631438)

  • 1. Effects of sedative-hypnotics on sleep quality among patients with insomnia: evidence from an observational, pre-post study in India.
    Satheesh G; Puthean S; Sharma A; Mishra SR; Jose J; Kakkan S; Unnikrishnan MK
    Health Qual Life Outcomes; 2020 Jul; 18(1):212. PubMed ID: 32631438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in prescriptions for sedative-hypnotics among Korean adults: a nationwide prescription database study for 2011-2015.
    Lee MH; Choi JW; Lee J; Shin A; Oh SM; Jung SJ; Lee YJ
    Soc Psychiatry Psychiatr Epidemiol; 2019 Apr; 54(4):477-484. PubMed ID: 30406284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial.
    Maroo N; Hazra A; Das T
    Indian J Pharmacol; 2013; 45(1):34-9. PubMed ID: 23543804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of quality of sleep and the use of drugs with sedating properties in hospitalized adult patients.
    Frighetto L; Marra C; Bandali S; Wilbur K; Naumann T; Jewesson P
    Health Qual Life Outcomes; 2004 Mar; 2():17. PubMed ID: 15040803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zolpidem, a valuable alternative to benzodiazepine hypnotics for chronic insomnia?
    Declerck A; Smits M
    J Int Med Res; 1999; 27(6):253-63. PubMed ID: 10726234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sleep promoters and insomnia].
    Poyares D; Pinto LR; Tavares S; Barros-Vieira S
    Braz J Psychiatry; 2005 May; 27 Suppl 1():2-7. PubMed ID: 16082448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use.
    Morgan K; Dixon S; Mathers N; Thompson J; Tomeny M
    Health Technol Assess; 2004 Feb; 8(8):iii-iv, 1-68. PubMed ID: 14960254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Main neuroendocrine features and therapy in primary sleep troubles.
    Amihăesei IC; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem.
    Roehrs TA; Roth T
    J Clin Sleep Med; 2016 Mar; 12(3):319-25. PubMed ID: 26446253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy.
    Nowell PD; Mazumdar S; Buysse DJ; Dew MA; Reynolds CF; Kupfer DJ
    JAMA; 1997 Dec 24-31; 278(24):2170-7. PubMed ID: 9417012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep complaints: Whenever possible, avoid the use of sleeping pills.
    Prescrire Int; 2008 Oct; 17(97):206-12. PubMed ID: 19536941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with long-term use of hypnotics among patients with chronic insomnia.
    Takaesu Y; Komada Y; Asaoka S; Kagimura T; Inoue Y
    PLoS One; 2014; 9(11):e113753. PubMed ID: 25409018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxepin is more effective than zolpidem in improving executive function in patients with insomnia disorder.
    Yu Z; Han L; Yan P; Liu W; Ren L; Xu Y; Yang L; Ma L; Liu Y; Wang S
    Sleep Breath; 2024 May; 28(2):929-934. PubMed ID: 38123719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of sleep-related medications prescribed to elderly outpatients with insomnia in Taiwan.
    Huang WF; Lai IC
    Drugs Aging; 2005; 22(11):957-65. PubMed ID: 16323972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing Sedative-Hypnotics Among Hospitalized Patients: a Multi-centered Study.
    Soong C; Ethier C; Lee Y; Othman D; Burry L; Wu PE; Ng KA; Matelski J; Liu B
    J Gen Intern Med; 2022 Aug; 37(10):2345-2350. PubMed ID: 34981347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R; Rüther E; Farr I; Emilien G; Salinas E
    J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of short-acting hypnotics.
    Mendelson WB; Jain B
    Drug Saf; 1995 Oct; 13(4):257-70. PubMed ID: 8573298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contribution of zolpidem in the management of sleep disorders].
    Lavoisy J; Zivkovic B; Benavides J; Perrault GH; Robert P
    Encephale; 1992; 18(4):379-92. PubMed ID: 1363657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.
    Perlis ML; McCall WV; Krystal AD; Walsh JK
    J Clin Psychiatry; 2004 Aug; 65(8):1128-37. PubMed ID: 15323600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.